LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes.
Andrea ManciniErik StoopsLeentje DemeyerGiovanni BellomoFederico Paolini PaolettiLorenzo GaetaniMassimiliano Di FilippoLucilla ParnettiPublished in: Movement disorders : official journal of the Movement Disorder Society (2023)
The tested immunoassay may represent a reliable method for assessing CSF LRRK2 levels. The results appear to confirm an association of LRRK2 alteration with cognitive impairment in PD. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.